167 related articles for article (PubMed ID: 9277043)
21. Analysis of lymphocyte subsets in patients with aplastic anemia before and during immunosuppressive therapy.
Mentzel U; Vogt H; Rossol R; Geissler RG; Maurer A; Ganser A; Trommer WE; Hoelzer D
Ann Hematol; 1993 Mar; 66(3):127-9. PubMed ID: 8471657
[TBL] [Abstract][Full Text] [Related]
22. Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by V beta CDR3 spectratyping and flow cytometry.
Risitano AM; Kook H; Zeng W; Chen G; Young NS; Maciejewski JP
Blood; 2002 Jul; 100(1):178-83. PubMed ID: 12070025
[TBL] [Abstract][Full Text] [Related]
23. T-cell receptor beta chain variability in bone marrow and peripheral blood in severe acquired aplastic anemia.
Manz CY; Dietrich PY; Schnuriger V; Nissen C; Wodnar-Filipowicz A
Blood Cells Mol Dis; 1997; 23(1):110-22. PubMed ID: 9215756
[TBL] [Abstract][Full Text] [Related]
24. Seeing the good and bad in aplastic anemia: is autoimmunity in AA dysregulated or antineoplastic?
Nissen C; Schubert J
Hematol J; 2002; 3(4):169-75. PubMed ID: 12189561
[TBL] [Abstract][Full Text] [Related]
25. The herbal decoction modified Danggui Buxue Tang attenuates immune-mediated bone marrow failure by regulating the differentiation of T lymphocytes in an immune-induced aplastic anemia mouse model.
Deng P; Li X; Wei Y; Liu J; Chen M; Xu Y; Dong B; Zhu L; Chai L
PLoS One; 2017; 12(7):e0180417. PubMed ID: 28683082
[TBL] [Abstract][Full Text] [Related]
26. Changes in T-cell receptor VB repertoire in aplastic anemia: effects of different immunosuppressive regimens.
Kook H; Risitano AM; Zeng W; Wlodarski M; Lottemann C; Nakamura R; Barrett J; Young NS; Maciejewski JP
Blood; 2002 May; 99(10):3668-75. PubMed ID: 11986222
[TBL] [Abstract][Full Text] [Related]
27. Detection and Significance of CD4+CD25+CD127dim Regulatory T Cells in Individuals with Severe Aplastic Anemia.
Qi W; Ren Y; Fu R; Wang H; Liu C; Shao Z
Turk J Haematol; 2015 Sep; 32(3):220-7. PubMed ID: 25912955
[TBL] [Abstract][Full Text] [Related]
28. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
[TBL] [Abstract][Full Text] [Related]
29. Limited heterogeneity of T cell receptor BV usage in aplastic anemia.
Zeng W; Maciejewski JP; Chen G; Young NS
J Clin Invest; 2001 Sep; 108(5):765-73. PubMed ID: 11544283
[TBL] [Abstract][Full Text] [Related]
30. Abnormalities of quantities and functions of linker for activations of T cells in severe aplastic anemia.
Sheng W; Liu C; Fu R; Wang H; Qu W; Ruan E; Wang G; Liu H; Wu Y; Song J; Xing L; Guan J; Li L; Liu H; Shao Z
Eur J Haematol; 2014 Sep; 93(3):214-23. PubMed ID: 24673455
[TBL] [Abstract][Full Text] [Related]
31. Expression of interferon-gamma and tumor necrosis factor-alpha in bone marrow T cells and their levels in bone marrow plasma in patients with aplastic anemia.
Dubey S; Shukla P; Nityanand S
Ann Hematol; 2005 Sep; 84(9):572-7. PubMed ID: 15815907
[TBL] [Abstract][Full Text] [Related]
32. Minor antigen h60-mediated aplastic anemia is ameliorated by immunosuppression and the infusion of regulatory T cells.
Chen J; Ellison FM; Eckhaus MA; Smith AL; Keyvanfar K; Calado RT; Young NS
J Immunol; 2007 Apr; 178(7):4159-68. PubMed ID: 17371972
[TBL] [Abstract][Full Text] [Related]
33. Functional characterization of CD4+ T cells in aplastic anemia.
Kordasti S; Marsh J; Al-Khan S; Jiang J; Smith A; Mohamedali A; Abellan PP; Veen C; Costantini B; Kulasekararaj AG; Benson-Quarm N; Seidl T; Mian SA; Farzaneh F; Mufti GJ
Blood; 2012 Mar; 119(9):2033-43. PubMed ID: 22138514
[TBL] [Abstract][Full Text] [Related]
34. Deficiency of CD34+ c-kit+ and CD34+38- hematopoietic precursors in aplastic anemia after immunosuppressive treatment.
Manz CY; Nissen C; Wodnar-Filipowicz A
Am J Hematol; 1996 Aug; 52(4):264-74. PubMed ID: 8701944
[TBL] [Abstract][Full Text] [Related]
35. Association of aplastic anemia and FoxP3 gene polymorphisms in Koreans.
In JW; Lee N; Roh EY; Shin S; Park KU; Song EY
Hematology; 2017 Apr; 22(3):149-154. PubMed ID: 27702400
[TBL] [Abstract][Full Text] [Related]
36. [Preliminary study on predictors for selection of immunosuppressive therapy or androgens in treating aplastic anemia patients].
Tang XD; Zhang SS; Ma R
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Feb; 29(2):106-10. PubMed ID: 19382467
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure.
Maciejewski JP; Hibbs JR; Anderson S; Katevas P; Young NS
Exp Hematol; 1994 Oct; 22(11):1102-10. PubMed ID: 7925777
[TBL] [Abstract][Full Text] [Related]
38. Shared and individual specificities of immunodominant cytotoxic T-cell clones in paroxysmal nocturnal hemoglobinuria as determined by molecular analysis.
Plasilova M; Risitano AM; O'Keefe CL; Rodriguez A; Wlodarski M; Young NS; Maciejewski J
Exp Hematol; 2004 Mar; 32(3):261-9. PubMed ID: 15003311
[TBL] [Abstract][Full Text] [Related]
39. Antigen-recognition sites of micromanipulated T cells in patients with acquired aplastic anemia.
Piao W; Grosse J; Czwalinna A; Ivanyi P; Ganser A; Franzke A
Exp Hematol; 2005 Jul; 33(7):804-10. PubMed ID: 15963856
[TBL] [Abstract][Full Text] [Related]
40. Transcript profile of CD4+ and CD8+ T cells from the bone marrow of acquired aplastic anemia patients.
Zeng W; Kajigaya S; Chen G; Risitano AM; Nunez O; Young NS
Exp Hematol; 2004 Sep; 32(9):806-14. PubMed ID: 15345281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
